High-fructose diet leads to visceral adiposity and hypothalamic leptin resistance in male rats - do glucocorticoids play a role?

Journal of Nutritional Biochemistry

Volumn 25, Issue 4, 2014, Pages 446-455

  Bursać, Biljana N ^a   Vasiljević, Ana D ^a   Nestorović, Nataša M ^a   Veličković, Nataša A ^a   Vojnović Milutinović, Danijela D ^a   Matić, Gordana M ^a   Djordjevic, Ana D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Adipogenesis; Fructose; Glucocorticoids; Hypothalamus; Leptin; Visceral adipose tissue

Indexed keywords

FRUCTOSE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LEPTIN; LIPIN 1; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; LEPTIN RECEPTOR; LIPIN-1 PROTEIN, RAT; NUCLEAR PROTEIN; SOCS3 PROTEIN, RAT; SREBF1 PROTEIN, RAT; SUPPRESSOR OF CYTOKINE SIGNALING;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIET; DYSLIPIDEMIA; ENZYME ACTIVITY; HYPOTHALAMUS; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; MALE; METABOLISM; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WISTAR RAT; ADIPOCYTE; ANIMAL; DRUG EFFECTS; GENETICS; PATHOLOGY;

RATTUS; RATTUS NORVEGICUS;

ADIPOCYTES; ADIPOSITY; ANIMALS; DIET; FRUCTOSE; HYPOTHALAMUS; INTRA-ABDOMINAL FAT; LEPTIN; LIPID METABOLISM; MALE; NEUROPEPTIDE Y; NUCLEAR PROTEINS; PPAR GAMMA; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, LEPTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84895919149     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.12.005     Document Type: Article

References (89)

1. Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005, 2:5.
2. Miller A., Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008, 24:204-209.
3. Tappy L., Le K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010, 90:23-46.
4. Dekker M.J., Su Q., Baker C., Rutledge A.C., Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010, 299:E685-E694.
5. Elliott S.S., Keim N.L., Stern J.S., Teff K., Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002, 76:911-922.
6. Shapiro A., Tumer N., Gao Y., Cheng K.Y., Scarpace P.J. Prevention and reversal of diet-induced leptin resistance with a sugar-free diet despite high fat content. Br J Nutr 2011, 106:390-397.
7. Oswal A., Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring) 2010, 18:221-229.
8. Dardeno T.A., Chou S.H., Moon H.S., Chamberland J.P., Fiorenza C.G., Mantzoros C.S. Leptin in human physiology and therapeutics. Front Neuroendocrinol 2010, 31:377-393.
9. Morrison C.D. Leptin signaling in brain: a link between nutrition and cognition?. Biochim Biophys Acta 2009, 1792:401-408.
10. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008, 70:537-556.
11. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
12. Friedman J.M. Leptin, leptin receptors, and the control of body weight. Nutr Rev 1998, 56:38-46. [discussion s54-75].
13. Wang M. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab (Lond). 2005, 2:3.
14. Walker B.R. Cortisol - cause and cure for metabolic syndrome?. Diabet Med 2006, 23:1281-1288.
15. Zhang Y.L., Zhong X., Gjoka Z., Li Y., Stochaj W., Stahl M., et al. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis. Arch Biochem Biophys 2009, 483:45-54.
16. Rose A.J., Vegiopoulos A., Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J Steroid Biochem Mol Biol 2010, 122:10-20.
17. Seckl J.R., Morton N.M., Chapman K.E., Walker B.R. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 2004, 59:359-393.
18. Campbell J.E., Peckett A.J., D'Souza A.M., Hawke T.J., Riddell M.C. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am J Physiol Cell Physiol 2011, 300:C198-C209.
19. Wang J.C., Gray N.E., Kuo T., Harris C. Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci. 2012, 2:19.
20. Peckett A.J., Wright D.C., Riddell M.C. The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 2011, 60:1500-1510.
21. Rosen E.D., Spiegelman B.M. PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001, 276:37731-37734.
22. Medina-Gomez G., Gray S.L., Yetukuri L., Shimomura K., Virtue S., Campbell M., et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 2007, 3:e64.
23. Berthiaume M., Sell H., Lalonde J., Gelinas Y., Tchernof A., Richard D., et al. Actions of PPARgamma agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1116-R1123.
24. Fajas L., Debril M.B., Auwerx J. PPAR gamma: an essential role in metabolic control. Nutr Metab Cardiovasc Dis 2001, 11:64-69.
25. Cock T.A., Back J., Elefteriou F., Karsenty G., Kastner P., Chan S., et al. Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen. EMBO Rep 2004, 5:1007-1012.
26. Tontonoz P., Kim J.B., Graves R.A., Spiegelman B.M. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993, 13:4753-4759.
27. Muhlhausler B., Smith S.R. Early-life origins of metabolic dysfunction: role of the adipocyte. Trends Endocrinol Metab 2009, 20:51-57.
28. Shimizu H., Arima H., Watanabe M., Goto M., Banno R., Sato I., et al. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology 2008, 149:4544-4553.
29. Velickovic N., Djordjevic A., Vasiljevic A., Bursac B., Milutinovic D.V., Matic G. Tissue-specific regulation of inflammation by macrophage migration inhibitory factor and glucocorticoids in fructose-fed Wistar rats. Br J Nutr 2013, 1-10.
30. Duncombe W.G. The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 1964, 9:122-125.
31. Galarraga M., Campion J., Munoz-Barrutia A., Boque N., Moreno H., Martinez J.A., et al. Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections. J Lipid Res 2012, 53:2791-2796.
32. Djordjevic A., Vojnovic Milutinovic D., Tanic N., Bursac B., Vasiljevic A., Velickovic N., et al. Identification of suitable reference genes for gene expression studies in tissues from fructose-fed rats. Adv Sci Lett 2012, 5:560-565.
33. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001, 25:402-408.
34. Park S.K., Oh S.Y., Lee M.Y., Yoon S., Kim K.S., Kim J.W. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Diabetes 2004, 53:2757-2766.
35. Spencer R.L., Kalman B.A., Cotter C.S., Deak T. Discrimination between changes in glucocorticoid receptor expression and activation in rat brain using Western blot analysis. Brain Res 2000, 868:275-286.
36. Bursac B.N., Djordjevic A.D., Vasiljevic A.D., Milutinovic D.D., Velickovic N.A., Nestorovic N.M., et al. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem 2013, 24:1166-1172.
37. Spector T. Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 micrograms of protein. Anal Biochem 1978, 86:142-146.
38. Rizkalla S.W. Health implications of fructose consumption: a review of recent data. Nutr Metab (Lond). 2010, 7:82.
39. Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004, 79:537-543.
40. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005, 63:133-157.
41. Kanarek R.B., Orthen-Gambill N. Differential effects of sucrose, fructose and glucose on carbohydrate-induced obesity in rats. J Nutr 1982, 112:1546-1554.
42. Jurgens H., Haass W., Castaneda T.R., Schurmann A., Koebnick C., Dombrowski F., et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 2005, 13:1146-1156.
43. Williams V.P., Szepesi B. Effect of dietary carbohydrates on food efficiency and body composition in adult male rats during normal growth and during recovery from food restriction. Nut Res. 1983, 5:457-468.
44. Vrana A., Fabry P., Kazdova L. Effect of dietary fructose on fatty acid synthesis in adipose tissue and on triglyceride concentration in blood in the rat. Nutr Metab 1973, 15:305-313.
45. Reiser S., Hallfrisch J. Insulin sensitivity and adipose tissue weight of rats fed starch or sucrose diets ad libitum or in meals. J Nutr 1977, 107:147-155.
46. Hallfrisch J., Blakely S.R., et al. Long-term effects of moderate fructose feeding on lipogenic parameters in Wistar rats. Nutr Rep Int 1982, 25:675-685.
47. Huang D.Y., Boini K.M., Friedrich B., Metzger M., Just L., Osswald H., et al. Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1. Am J Physiol Regul Integr Comp Physiol 2006, 290:R935-R944.
48. Shapiro A., Mu W., Roncal C., Cheng K.Y., Johnson R.J., Scarpace P.J. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 2008, 295:R1370-R1375.
49. Shapiro A., Cheng K.Y., Gao Y., Seo D.O., Anton S., Carter C.S., et al. The act of voluntary wheel running reverses dietary hyperphagia and increases leptin signaling in ventral tegmental area of aged obese rats. Gerontology 2011, 57:335-342.
50. Scarpace P.J., Zhang Y. Leptin resistance: a prediposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2009, 296:R493-R500.
51. Lee Y.C., Ko Y.H., Hsu Y.P., Ho L.T. Plasma leptin response to oral glucose tolerance and fasting/re-feeding tests in rats with fructose-induced metabolic derangements. Life Sci 2006, 78:1155-1162.
52. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
53. Banks W.A., Coon A.B., Robinson S.M., Moinuddin A., Shultz J.M., Nakaoke R., et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004, 53:1253-1260.
54. Friedman J.M. The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002, 60:1-14. [discussion S68-84, 5-7].
55. Levin B.E., Dunn-Meynell A.A. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2002, 283:R941-R948.
56. White D.W., Tartaglia L.A. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev 1996, 7:303-309.
57. Munzberg H., Flier J.S., Bjorbaek C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004, 145:4880-4889.
58. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H., et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 2004, 10:739-743.
59. Beck B. Neuropeptide Y, in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond B Biol Sci 2006, 361:1159-1185.
60. Ammar A.A., Sederholm F., Saito T.R., Scheurink A.J., Johnson A.E., Sodersten P. NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior. Am J Physiol Regul Integr Comp Physiol 2000, 278:R1627-R1633.
61. Benoit S.C., Clegg D.J., Woods S.C., Seeley R.J. The role of previous exposure in the appetitive and consummatory effects of orexigenic neuropeptides. Peptides 2005, 26:751-757.
62. Stanley B.G., Leibowitz S.F. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A 1985, 82:3940-3943.
63. Stanley B.G., Daniel D.R., Chin A.S., Leibowitz S.F. Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 1985, 6:1205-1211.
64. Stanley B.G., Anderson K.C., Grayson M.H., Leibowitz S.F. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol Behav 1989, 46:173-177.
65. Freedman M.R., Castonguay T.W., Stern J.S. Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats. Am J Physiol 1985, 249:R584-R594.
66. Uchoa E.T., Sabino H.A., Ruginsk S.G., Antunes-Rodrigues J., Elias L.L. Hypophagia induced by glucocorticoid deficiency is associated with an increased activation of satiety-related responses. J Appl Physiol 2009, 106:596-604.
67. Zakrzewska K.E., Sainsbury A., Cusin I., Rouru J., Jeanrenaud B., Rohner-Jeanrenaud F. Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids. Endocrinology 1999, 140:3183-3187.
68. Dallman M.F., Pecoraro N.C., La Fleur S.E., Warne J.P., Ginsberg A.B., Akana S.F., et al. Glucocorticoids, chronic stress, and obesity. Prog Brain Res 2006, 153:75-105.
69. Jeanrenaud B., Rohner-Jeanrenaud F. CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status. Int J Obes Relat Metab Disord 2000, 24(Suppl 2):S74-S76.
70. York D.A. Lessons from animal models of obesity. Endocrinol Metab Clin North Am 1996, 25:781-800.
71. Havel P.J. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001, 226:963-977.
72. Freeman A.I., Munn H.L., Lyons V., Dammermann A., Seckl J.R., Chapman K.E. Glucocorticoid down-regulation of rat glucocorticoid receptor does not involve differential promoter regulation. J Endocrinol 2004, 183:365-374.
73. Smith J., Al-Amri M., Dorairaj P., Sniderman A. The adipocyte life cycle hypothesis. Clin Sci (Lond) 2006, 110:1-9.
74. Faraj M., Lu H.L., Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 2004, 82:170-190.
75. Qatanani M., Lazar M.A. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 2007, 21:1443-1455.
76. Tomlinson J.W., Finney J., Hughes B.A., Hughes S.V., Stewart P.M. Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss. Diabetes 2008, 57:1536-1543.
77. Milagro F.I., Campion J., Martinez J.A. 11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity. J Steroid Biochem Mol Biol 2007, 104:81-84.
78. Mussig K., Remer T., Haupt A., Gallwitz B., Fritsche A., Haring H.U., et al. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. Obesity (Silver Spring) 2008, 16:1256-1260.
79. Hinds T.D., Stechschulte L.A., Cash H.A., Whisler D., Banerjee A., Yong W., et al. Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma (PPARgamma). J Biol Chem 2011, 286:42911-42922.
80. Semple R.K., Chatterjee V.K., O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest 2006, 116:581-589.
81. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999, 42:1033-1049.
82. Bhatia V., Viswanathan P. Insulin resistance and PPAR insulin sensitizers. Curr Opin Investig Drugs 2006, 7:891-897.
83. Tontonoz P., Hu E., Devine J., Beale E.G., Spiegelman B.M. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995, 15:351-357.
84. Savage D.B. PPAR gamma as a metabolic regulator: insights from genomics and pharmacology. Expert Rev Mol Med 2005, 7:1-16.
85. Huang J.V., Greyson C.R., Schwartz G.G. PPAR-gamma as a therapeutic target in cardiovascular disease: evidence and uncertainty. J Lipid Res 2012, 53:1738-1754.
86. Kim J.B., Spiegelman B.M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996, 10:1096-1107.
87. Takahashi Y., Shinoda A., Furuya N., Harada E., Arimura N., Ichi I., et al. Perilipin-mediated lipid droplet formation in adipocytes promotes sterol regulatory element-binding protein-1 processing and triacylglyceride accumulation. PLoS One 2013, 8:e64605.
88. Harris T.E., Finck B.N. Dual function lipin proteins and glycerolipid metabolism. Trends Endocrinol Metab 2011, 22:226-233.
89. Koh Y.K., Lee M.Y., Kim J.W., Kim M., Moon J.S., Lee Y.J., et al. Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2. J Biol Chem 2008, 283:34896-34906.